Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic Disorders

Condition:   Stem Cell Transplantation Interventions:   Drug: Fludarabine;   Drug: Dexamethasone;   Drug: Cyclophosphamide;   Drug: Bortezomib;   Drug: Rituximab;   Drug: Busulfan;   Drug: Cyclophosphamide (Cy);   Drug: Tacrolimus (or cyclosporine);   Drug: Mycophenolate mofetil (MMF);   Drug: Rabbit ATG Sponsor:   M.D. Anderson Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials